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Mast cells (MCs) are recognized to secrete a 
multitude  of  mediators,  including  cytokines 
and proteases, which enables them to play an 
important  role  in  the  initiation  and  mainte-
nance  of  appropriate,  selective,  and  effective 
immune responses as well as in allergic diseases 
(Blank and Rivera, 2004; Kinet, 2007; Brown   
et al., 2008; Kalesnikoff and Galli, 2008). Acti-
vation of MCs via FcRI triggering causes the 
immediate  degranulation  and  release  of  pre-
formed mediators from secretory granules, as 
well as de novo synthesis of cytokines, which 
are secreted after vesicular trafficking via the ER 
and  Golgi  complex.  Recent  work  acknowl-
edges an important role of the actin cytoskele-
ton in MC exocytosis (Frigeri and Apgar, 1999; 
Nishida et al., 2005; Sasaki et al., 2005). How-
ever, controversial findings have raised questions 
regarding the specific function and regulation 
of the actin cytoskeleton in secretory processes 
(Eitzen, 2003; Malacombe et al., 2006).
Coronins constitute a family of evolution-
ary  highly  conserved WD  repeat–containing 
proteins that have been implicated in the regu-
lation of actin cytoskeletal dynamics (Uetrecht 
and Bear, 2006; Clemen et al., 2008). Diverse 
functions of coronin proteins on actin filaments 
have been reported, including actin binding/
bundling, actin disassembly, and inhibition of 
the Arp2/3 complex (Humphries et al., 2002; 
Cai et al., 2007a,b; Galkin et al., 2008; Kueh   
et al., 2008; Gandhi et al., 2009). In mammali-
ans, seven coronin family members have been 
described. A high degree of sequence similari-
ties among coronin family proteins suggests 
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Mast cell (MC) activation via aggregation of the high affinity IgE receptor (FcRI) causes 
degranulation and release of proinflammatory mediators in a process that involves the 
reorganization of the actin cytoskeleton. However, the regulatory pathways and the molec­
ular links between cytoskeletal changes and MC function are incompletely understood.  
In this study, we provide genetic evidence for a critical role of the actin­regulatory proteins 
Coronin1a (Coro1a) and Coro1b on exocytic pathways in MCs: Coro1a/ bone marrow–
derived MCs exhibit increased FcRI­mediated degranulation of secretory lysosomes but 
significantly reduced secretion of cytokines. Hyperdegranulation of Coro1a/ MCs is 
further augmented by the additional loss of Coro1b. In vivo, Coro1a/Coro1b/ mice 
displayed enhanced passive cutaneous anaphylaxis. Functional reconstitution assays  
revealed that the inhibitory effect of Coro1a on MC degranulation strictly correlates with 
cortical localization of Coro1a, requires its filamentous actin–binding activity, and is regu­
lated by phosphorylation of Ser2 of Coro1a. Thus, coronin proteins, and in turn the actin 
cytoskeleton, exhibit a functional dichotomy as differential regulators of degranulation 
versus cytokine secretion in MC biology.
© 2011 Föger et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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MC development is not impaired in the absence of Coro1a 
and Coro1b.
To evaluate whether Coro1a and Coro1b regulate MC 
function in vivo, we examined passive cutaneous anaphylaxis 
(PCA), an MC-dependent, IgE-mediated experimental model 
which reflects in situ MC mediator release (Inagaki et al., 
1986; Wershil  et  al.,  1987).  PCA  was  induced  by  antigen 
(DNP human serum albumin [DNP-HSA]) challenge of mice 
that had been sensitized by intradermal ear injections with 
anti-DNP IgE. The subsequent assessment of IgE-dependent 
ear swelling revealed that Coro1a/Coro1b/ mice devel-
oped a significantly enhanced PCA reaction compared with 
WT mice (Fig. 2 a), thus indicating a physiological function 
of coronin proteins in MC biology and allergic responses.
To provide a cellular basis for the increased cutaneous 
anaphylaxis  in  Coro1a/Coro1b/  mice,  we  examined 
FcRI-mediated MC degranulation in coronin-deficient 
BMMCs by measuring the release of -hexosaminidase from 
prestored MC granules. Interestingly, antigen-mediated cross-
linking of FcRI resulted in significantly enhanced release of   
-hexosaminidase activity from Coro1a/ BMMCs as com-
pared with WT cells (Fig. 2 b). Although Coro1b/ BMMCs 
showed normal degranulation, the additional loss of Coro1b 
further increased hyperdegranulation in Coro1a/ BMMCs. 
For maximal activation, cells were also stimulated with PMA/
ionomycin, which overrides the observed hyperdegranulation 
phenotype of Coro1a/Coro1b/ BMMCs.
Increased  FcRI-mediated  degranulation  of  Coro1a/ 
and Coro1a/Coro1b/ BMMCs was further confirmed by 
assessing the up-regulation of CD107a cell surface expression, 
which is a marker for granule exocytosis (Fig. 2 c). Again,   
hyperdegranulation was more pronounced in Coro1a/ 
Coro1b/  BMMCs  compared  with  Coro1a/  BMMCs, 
whereas  Coro1b/  cells  showed  no  significant  difference 
from WT cells. Together, these data identify Coro1a as a nega-
tive regulator of FcRI-mediated MC degranulation. Fur-
thermore,  because  the  double  deficiency  of  Coro1a  and 
Coro1b exacerbates the Coro1a/ hyperdegranulation phe-
notype, Coro1b also contributes an overlapping role in regu-
lating MC activities.
To further determine a role of coronins in FcRI-mediated 
cytokine secretion, supernatants of BMMCs sensitized with 
anti-DNP  IgE  and  stimulated  with  DNP-HSA  were  col-
lected  and  tested  for  cytokine  production.  IL-6  and TNF   
secretion was not significantly affected by the single loss of 
Coro1b  (Fig.  2  d).  However,  in  striking  contrast  to  the   
observed hyperdegranulation of Coro1a/ BMMCs, the re-
lease  of  both  IL-6  and TNF  was  substantially  reduced  in 
Coro1a/ BMMCs compared with WT cells (Fig. 2 d), indi-
cating a critical role for Coro1a in FcRI-mediated cytokine 
secretion. The additional loss of Coro1b in Coro1a/Coro1b/ 
BMMCs had no effect on cytokine production. Notably, the 
reduced detection of IL-6 and TNF in cell supernatants of 
Coro1a/ and Coro1a/Coro1b/ BMMCs was not sec-
ondary to reduced synthesis of these cytokines, as intracellular 
flow cytometric staining revealed normal to slightly enhanced 
conserved features and functions. However, individual family 
members may have developed additional selective and spe-
cific  functions.  Based  on  their  phylogenetic  relationship, 
mammalian coronins have been divided into three different 
types: type I (Coro1a, Coro1b, Coro1c, and Coro6), type II 
(Coro2a and Coro2b), and type III (Coro7). In humans and 
mice, mutation or deletion of Coro1a, which is preferentially 
expressed in hematopoietic cells, results in a severe combined 
immunodeficiency that has mainly been attributed to defec-
tive actin regulation in T lymphocytes (Föger et al., 2006; 
Mugnier et al., 2008; Shiow et al., 2008). Coro1a is also re-
quired for the survival of mycobacteria in phagosomes of   
infected macrophages (Jayachandran et al., 2007). The role of 
coronins in the regulation of MC activities is largely unknown.
RESULTS AND DISCUSSION
To investigate the impact of coronins on MC function, we 
first determined the expression pattern of coronins. Real-
time PCR analysis revealed expression of Coro1a, Coro1b, 
Coro1c, Coro2a, and Coro7 messenger RNA (mRNA) in 
MCs, whereas the other coronin family members, Coro2b 
and Coro6, could not be detected (Fig. S1 a). Within the clas-
sical actin regulatory type I coronins, expression was highest 
for Coro1a and Coro1b, and our further experiments focused 
on these two coronin proteins. Expression of Coro1a and 
Coro1b was confirmed on the protein level by Western blot-
ting (Fig. 1 a). Confocal microscopy revealed that Coro1a is 
primarily localized at the filamentous actin (F-actin)–rich cell 
cortex in MCs but also exhibits some punctuate cytoplasmic 
staining,  which  only  minimally  colocalized  with  CD107a 
(Lamp1)+ secretory lysosomes (Fig. 1 b, 1–9; Fig. S1 f; and   
Table S2). Cortical localization was instead less pronounced 
for Coro1b (Fig. 1 b, 10–18).
Importantly, MC stimulation via antigen-specific cross-
linking of FcRI induced the transient phosphorylation of 
Coro1a and Coro1b on Ser residues, including the regulatory 
Ser at position 2 (Ser2) of Coro1b (Fig. 1, c and d; and Fig. S1 g), 
suggesting a regulatory role of Coro1a and Coro1b and, in 
turn, the actin cytoskeleton in MC function.
We next established IL-3–dependent BM-derived MC 
(BMMC) cultures from Coro1a/, Coro1b/, and Coro1a/ 
Coro1b/ mice and compared them with the ones obtained 
from WT  control  mice.  BMMCs  expressed  similar  levels   
of selected MC surface markers, c-Kit, FcRI, and T1/ST2   
(Fig. 1 e), and MC-specific genes, such as those encoding for 
the chymases mMCP-1, mMCP-2, mMCP-5, and mMCP-9, 
were expressed in similar amounts (Fig. 1 g). Also, the total 
amount of -hexosaminidase activity per cell was comparable 
between all genotypes (Fig. S3 a). Furthermore, Coro1a and/or 
Coro1b protein was lacking in BMMCs of the respective KO 
genotype (Fig. 1 f ), indicating no compensatory expression 
between the two coronins family members. A histological 
analysis also indicated comparable frequency and localization of 
MCs  in  different  tissues  of WT  and  Coro1a/Coro1b/ 
mice, as well as normal numbers and morphology of perito-
neal MCs (Fig. S2, f–k). These results collectively indicate that JEM Vol. 208, No. 9  1779
Brief Definitive Report
As shown in Fig. 2 g, similar phosphorylation levels and com-
parable kinetics were observed among BMMCs of all four 
genotypes. Similarly, normal phosphorylation of the protein 
kinases Akt (Ser473) and p90Rsk (Ser380; Fig. 2 g) was detected. 
Because Coro1a has been implicated in the regulation of Ca2+ 
signaling in T lymphocytes (Mueller et al., 2008), we exam-
ined the FcRI-mediated Ca2+ influx in Coro1a/Coro1b/ 
BMMCs  and  compared  it  with  the  one  induced  in WT 
BMMCs. However, FcRI-mediated Ca2+ influx was compara-
ble between Coro1a/Coro1b/ and WT BMMCs (Fig. S3 d).
expression of IL-6 and TNF in Coro1a/, Coro1b/, and 
Coro1a/Coro1b/ BMMCs (Fig. 2 e and Fig. S3, e and f ). 
Consistent with these findings, FcRI-mediated induction of 
IL-6, IL-13, and TNF mRNA was similar between WT and 
coronin-deficient BMMCs (Fig. 2 f ).
To  examine  whether  coronins  are  required  for  IgE- 
dependent signaling events, FcRI-induced phosphorylation 
of the mitogen-activated protein kinases Erk1/Erk2 (Thr202/
Tyr204), p38 (Thr180/Tyr182), and JNK1/JNK2 (Thr183/
Tyr185) in coronin-deficient and WT BMMCs was investigated. 
Figure 1.  Expression, localization, and 
FcRI­induced Ser phosphorylation of 
Coro1a and Coro1b in BMMCs. (a) Immuno-
blot analysis of Coro1a and Coro1b expression 
in the indicated tissues or BM-derived cell 
types. Protein loading was assessed by analysis 
of -actin expression throughout the figure. 
Data are representative of two independent 
experiments. (b) Subcellular localization of 
Coro1a and Coro1b in BMMCs. BMMCs were 
fixed, permeabilized, and stained for either 
Coro1a (top [1–9]) or Coro1b (bottom [10–18]) 
together with phalloidin (F-actin), CD107a 
(Lamp1), and DAPI. Individual and overlay fluo-
rescence images were generated by confocal 
microscopy and are representative of at least 
three independent experiments. Bars, 5 µm.  
(c) Ser phosphorylation of Coro1a in response 
to FcRI triggering. WT BMMCs were sensitized 
with anti-DNP IgE and stimulated with DNP-
HSA. Coro1a was immunoprecipitated from 
lysates at the indicated times and immuno-
blotted with anti–p-SerPKC and anti-Coro1a to 
monitor Coro1a Ser phosphorylation. 
Coro1a/ BMMCs were used as negative con-
trols. Data are representative of three indepen-
dent experiments. (d) Phosphorylation of 
Coro1b on Ser2 in response to FcRI-mediated 
BMMC activation. WT BMMCs were sensitized 
with anti-DNP IgE and stimulated with DNP-
HSA for the indicated times. Whole cellular 
lysates were immunoblotted with anti–p-
Coro1b (Ser2) and anti-Coro1b. Coro1b/ 
BMMCs were used to control for antibody 
specificity. Data are representative of three 
independent experiments. (e) Flow cytometric 
analysis of c-Kit, FcRI-, and T1/ST2 surface 
expression in WT, Coro1a/ (C1a.KO), 
Coro1b/ (C1b.KO), and Coro1a/Coro1b/ 
(DKO) BMMCs. Data are representative of at 
least five independent experiments. (f ) Immuno-
blot analysis of Coro1a and Coro1b expression 
in BMMCs of the indicated genotype. Data are 
representative of at least three independent 
experiments. (g) RT-PCR analysis showing nor-
mal expression of mRNA encoding for the MC 
chymases MCP-1, MCP-2, MCP-5, and MCP-9. 
Data shown are from two independently gen-
erated BMMC lines for each genotype.1780 Coronins regulate secretory pathways in mast cells | Föger et al.
Figure 2.  Coro1a/Coro1b deficiency leads to enhanced IgE­dependent MC degranulation and impaired cytokine production. (a) Enhanced PCA 
reaction. Indicated mice received intradermal injections of anti-DNP IgE (or PBS as control) into the ears. After sensitization, mice were i.v. challenged 
with DNP-HSA as described in Materials and methods. PCA was quantified by monitoring ear thickness. Data are means ± SEM (WT, n = 5; DKO, n = 4; 
control treatment, 3 mice each). Results are representative for four independent PCA experiments. *, P < 0.001 compared with WT. (b) Increased FcRI-
induced -hexosaminidase release. WT, Coro1a/ (C1a.KO), Coro1b/ (C1b.KO), and Coro1a/Coro1b/ (DKO) BMMCs were sensitized with anti-DNP IgE 
and stimulated for 10 min with the indicated concentrations of DNP-HSA. Alternatively, cells were stimulated with PMA/ionomycin. Degranulation  
was assessed by measuring the release of -hexosaminidase activity as described in Materials and methods. Data are means ± SD of duplicate cultures 
and representative of at least three independent experiments. *, P < 0.001 compared with WT. (c) Increased FcRI-induced up-regulation of CD107a sur-
face expression. IgE-sensitized BMMCs were stimulated for 10 min with the indicated concentrations of DNP-HSA. Degranulation was assessed by flow 
cytometric analysis of CD107a cell surface expression. Numbers shown are the percentage of CD107a-positive cells. Data are representative of at least 
three independent experiments. (d) Decreased FcRI-mediated cytokine secretion. Sensitized BMMCs were stimulated for 4 h with the indicated concen-
trations of DNP-HSA. Release of IL-6 and TNF into the supernatant was measured by ELISA. Data are mean ± SEM from four cultures each. *, P < 0.05 
compared with WT cells at the indicated antigen concentrations. Data are representative of five independent experiments. (e) Intracellular cytokine pro-
duction. Sensitized BMMCs were stimulated for 4 h with the indicated concentrations of DNP-HSA in the presence of Brefeldin A. Cells were analyzed for 
intracellular IL-6 or TNF by flow cytometry, and graphs show the percentage of positive cells ± SEM from two independent experiments. (f ) Cytokine gene 
transcription. Sensitized BMMCs were stimulated for 1 h with DNP-HSA. mRNA levels for IL-6, TNF, and IL-13 were measured by real-time quantitative 
PCR. The expression level of nonstimulated WT BMMCs was set as 1. Data are mean ± SEM from two independent experiments. (g) FcRI-induced signal-
ing. Sensitized BMMCs were stimulated with 10 ng/ml DNP-HSA for the indicated times. Whole cellular lysates were subjected to immunoblot analysis 
using the indicated antibodies. Data are representative of at least three independent experiments.JEM Vol. 208, No. 9  1781
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Coro1a because hyperdegranulation 
is aggravated in Coro1a/Coro1b/ 
BMMCs compared with Coro1a/ 
cells. In addition, our findings indi-
cate that Coro1a and Coro1b do not 
affect  FcRI-dependent  signaling 
and cytokine expression in MCs.
To understand whether changes 
in the actin cytoskeleton are respon-
sible  for  the  differential  effect  on 
FcRI-mediated degranulation and cytokine secretion, we 
tested the effect of the actin modulatory drug latrunculin   
B on FcRI-mediated degranulation. Consistent with previous 
Together, our data suggest a differential role of coronins in 
FcRI-mediated degranulation and cytokine secretion. Fur-
thermore, Coro1b is able to substitute for some functions of 
Figure 3.  Dual function of the actin 
cytoskeleton in the regulation of MC 
degranulation and cytokine secretion.  
(a and b) Increased degranulation in latrun-
culin B–treated MCs. IgE-sensitized BMMCs 
pretreated with either 1 µg/ml latrunculin B 
or carrier (EtOH) were stimulated for 10 min 
with the indicated concentrations of DNP-
HSA (a) or 3 ng/ml DNP-HSA (b). Degranula-
tion was then determined by measuring the 
release of -hexosaminidase activity (means ± 
SD of triplicate samples; a) or flow cyto-
metric analysis of CD107a cell surface ex-
pression (b). *, P < 0.005 compared with 
control-treated cells at the indicated antigen 
concentrations. Data are representative  
of at least two independent experiments.  
(c and d) Decreased cytokine secretion in 
latrunculin B–treated MCs. IgE-sensitized 
BMMCs pretreated with either 1 µg/ml la-
trunculin B or carrier (EtOH) were stimulated 
for 4 h with the indicated concentrations of 
DNP-HSA. Release of IL-6 (c) and TNF (d) into 
the supernatant was measured by ELISA 
(means ± SD of triplicate samples) *, P < 0.05 
compared with control-treated cells at the 
indicated antigen concentrations. Data are 
representative of three independent experi-
ments. (e) Intracellular cytokine production 
in latrunculin B–treated MCs. Sensitized 
BMMCs pretreated with either 1 µg/ml la-
trunculin B or carrier (EtOH) were stimulated 
for 4 h with the indicated concentrations of 
DNP-HSA in the presence of Brefeldin A. 
Cells were analyzed for intracellular IL-6 or 
TNF by flow cytometry. Data are representa-
tive of two independent experiments.  
(f ) Cytokine gene transcription in latrunculin 
B–treated MCs. Sensitized BMMCs pre-
treated with either 1 µg/ml latrunculin B or 
carrier (EtOH) were stimulated for 1 h with 
DNP-HSA. mRNA levels for IL-6, TNF, and IL-13 
were measured by real-time quantitative 
PCR. Data are mean ± SEM from duplicate 
samples. Data are representative of two 
independent experiments.1782 Coronins regulate secretory pathways in mast cells | Föger et al.
of mRNA encoding for IL-6, IL-13, and TNF was 
similar to slightly enhanced upon treatment of 
BMMCs with latrunculin B (Fig. 3 f ). Collectively, 
these results suggest that the actin cytoskeleton reg-
ulates diverse aspects of MC function. Notably, 
treatment of BMMCs with latrunculin B  mim-
icked the opposing effects of coronin deficiency 
on MC degranulation and cytokine secretion.
Coro1a has been linked to the control of the 
cellular  steady-state  F-actin  content  in T  cells 
(Föger et al., 2006). However, in contrast to the 
massive  accumulation  of  F-actin  in  Coro1a/  
T cells (Föger et al., 2006; Mugnier et al., 2008; 
Shiow et al., 2008), only minor differences in cel-
lular F-actin levels were observed between WT, 
Coro1a/, Coro1b/, and Coro1a/Coro1b/ 
BMMCs (Fig. S4, a and b), reinforcing the idea of 
cell type– and/or context-specific differences in 
the actin regulatory activities of coronin proteins 
(Gandhi et al., 2009). To gain further insights into 
the role of the actin cytoskeleton and coronin 
proteins for MC function, we next investigated the intracellular 
F-actin structure, as well as the subcellular localization of Coro1a 
and Coro1b upon MC activation by confocal microscopy. MC 
stimulation induced characteristic changes in cell morphology 
that are associated with granule release, including cell spread-
ing and the formation of filopodia, membrane ridges, and 
craters (Fig. 4 a, bottom). Furthermore, MC activation resulted 
in the disassembly of the cortical F-actin ring (Fig. 4, a and b, 
3 and 7). As seen before in unstimulated BMMCs (Fig. 1 b), 
Coro1a predominantly exhibited a characteristic ring-like stain-
ing pattern at the cell periphery, where it colocalized with corti-
cal F-actin (Fig. 4 a). However, after activation of BMMCs,   
by either stimulation with PMA/ionomycin or antigen-specific 
studies (Nishida et al., 2005; Sasaki et al., 2005), BMMCs pre-
treated with latrunculin B exhibited an enhanced degranula-
tion in response to FcRI cross-linkage, as assessed by measuring 
-hexosaminidase release (Fig. 3 a) and by determining the 
increase in CD107a cell surface staining (Fig. 3 b). Further-
more, contrary to its enhancing effect on MC degranulation, 
treatment of BMMCs with latrunculin B resulted in decreased 
secretion of IL-6 and TNF in response to FcRI stimulation 
(Fig. 3, c and d). However, intracellular production of these 
cytokines was not affected by the treatment with latrunculin 
B, as intracellular FACS staining revealed comparable per-
centages of IL-6– and TNF-producing cells in latrunculin   
B– and control-treated BMMCs (Fig. 3 e). Also, the induction 
Figure 4.  FcRI­mediated MC activation induces  
the subcellular redistribution of Coro1a and Coro1b. 
(a and b) Confocal microscopy images showing the subcel-
lular localization of Coro1a (a, 2 and 6) and Coro1b (b, 2 
and 6) in unstimulated (1–4) and antigen-stimulated (5–8) 
BMMCs. Cells were sensitized with anti-DNP IgE (SPE-7) 
and either stimulated with 75 ng/ml DNP-HSA or control-
treated (unstimulated) for 10 min at 37°C. Cells were fixed, 
permeabilized, and stained for either Coro1a or Coro1b 
together with phalloidin (F-actin) and DAPI. Representative 
individual and overlay fluorescence images from two inde-
pendent experiments are shown. Bars, 5 µm. (c) Biochemi-
cal analysis of the subcellular localization of Coro1a and 
Coro1b. BMMCs either unstimulated or stimulated with 
PMA/ionomycin (20 min; left) or antigen (75 ng/ml DNP-
HSA; 2–60 min; right) were extracted in cytoskeleton isola-
tion buffer as described in Materials and methods. The 
detergent-insoluble pellet (P; cytoskeletal fraction) and the 
detergent-soluble supernatant (S; cytosolic fraction) were 
subjected to immunoblotting using the indicated anti-
bodies. As a control, BMMCs were pretreated with 1 µg/ml 
latrunculin B (15 min). Data are representative for at least 
three independent experiments.JEM Vol. 208, No. 9  1783
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these coronin proteins in response to MC activation was fur-
ther supported by biochemical fractionation experiments. In 
nonstimulated BMMCs, Coro1a and Coro1b were predomi-
nantly recovered in the detergent-insoluble F-actin–rich pel-
let (cytoskeletal fraction; Fig. 4 c). Activation of BMMCs by 
cross-linkage of FcRI, Coro1a relocalized from the cell cortex 
into the cytoplasm (Fig. 4 a, 6; and Fig. S4 d). Similarly, cortical 
Coro1b staining also got lost upon MC activation (Fig. 4 b, 6).
An association of Coro1a and Coro1b with the actin cyto-
skeleton in unstimulated MCs and subcellular relocation of 
Figure 5.  The inhibitory role of Coro1a on MC degranulation requires the interaction of Coro1a with actin cytoskeletal elements. (a and  
b) Subcellular localization of Coro1a mutants. Coro1a/ BMMCs were transfected with Flag-tagged WT (Coro1a FL) or mutant Coro1a internal ribosomal 
entry site–GFP expression constructs. (a) Cells were fixed, permeabilized, and stained for Coro1a, phalloidin (F-actin), and DAPI. Individual and overlay 
fluorescence images were obtained by confocal microscopy. Bars, 5 µm. (b) Cells were extracted in cytoskeleton isolation buffer as described in Materials 
and methods. The detergent-insoluble pellet (P; cytoskeletal fraction) and the detergent-soluble supernatant (S; cytosolic fraction) were subjected to  
immunoblotting using a Flag-specific antibody. Data are representative for two independent experiments. (c) Functional reconstitution of MC degranulation. 
Coro1a/Coro1b/ BMMCs were transfected with Flag-tagged WT (C1a) or mutant Coro1a internal ribosomal entry site–GFP expression constructs. 
Cells were sensitized with anti-DNP IgE and stimulated for 10 min with 10 ng/ml DNP-HSA. MC degranulation was assessed by flow cytometric analysis 
of CD107a cell surface expression on GFP+ (transfected) cells. Results represent the percentage of reduction in CD107a cell surface expression. Expression 
of coronin constructs was assessed in Fig. S5 a. Data are mean ± SEM of at least three independent experiments. *, P < 0.05 compared with Coro1a FL.1784 Coronins regulate secretory pathways in mast cells | Föger et al.
of Coro1a. Interestingly, no alterations in MC function were 
detected in MCs expressing a truncated mutant of Coro1a 
(Q262X Coro1a; Arandjelovic et al., 2010), possibly because 
of some residual regulatory activity of the mutant Coro1a 
protein. We propose that Coro1a exhibits no major effects on 
steady-state actin polymerization in unstimulated MCs but 
rather stabilizes the cortical network of actin filaments via its 
actin-binding and/or -bundling activity, thereby entrapping 
secretory granules and preventing unwanted granule release. 
This idea is consistent with the recently described F-actin 
decoration  and  stabilization  function  of  Coro1A  (Galkin   
et al., 2008). Actin-dependent processes have further been impli-
cated in the regulation of membrane trafficking from the ER 
to the Golgi and the plasma membrane (Müsch et al., 1997), 
a cellular transport route which is also used for release of 
newly synthesized cytokines. Normal synthesis but reduced 
secretion of cytokines in Coro1a/ MCs thus suggests that 
owing to its actin-regulatory function, Coro1a is involved 
in the control of vesicular trafficking in MCs. Together, our 
data provide genetic evidence to support the longstanding 
hypothesis that the cortical actin network acts as a physical 
barrier to prevent docking and fusion of secretory granules 
to the plasma membrane (Aunis and Bader, 1988).
Exocytosis is accompanied by a regulated reorganization 
of cortical actin filaments, which is then thought to allow for 
recruitment of granules to exocytic sites (Eitzen, 2003). Our 
data suggest that Coro1a and Coro1b are functionally in-
volved in the stimulus-dependent control of the stability and 
the dynamics of the cortical actin network. FcRI triggering 
induces  the  subcellular  relocation  of  Coro1a  and  Coro1b 
from  the  actin-rich  cell  cortex  to  the  cytoplasm,  thereby 
likely contributing to reduced cortical stability and better ac-
cess of secretory granules to the plasma membrane upon cel-
lular  activation. This  intracellular  redistribution  of  Coro1a 
and Coro1b in MCs is regulated by FcRI-mediated phos-
phorylation of Coro1a and Coro1b on the critical Ser2. This 
phosphorylation event has previously been demonstrated to 
reduce the interaction with the Arp2/3 complex (Cai et al., 
2005; Föger et al., 2006), which is a central component of the 
actin cytoskeleton. Thus, Ser2-phosphorylated coronin ex-
hibits reduced binding to the cortical actin network, which 
likely  annihilates  the  actin-dependent  negative  regulatory 
function of coronin on MC degranulation. Despite the high 
degree of sequence conservation between coronin family mem-
bers, Coro1b only partially compensates for Coro1a deficiency 
in MC degranulation and, in contrast to Coro1a, has no discern-
able effect on cytokine release. Thus, our findings indicate 
that coronin family members have developed both common 
and specialized functions.
In  conclusion,  distinct  secretory  pathways  have  funda-
mentally different requirements on coronin proteins and the 
actin cytoskeleton in MCs. These findings likely represent 
common regulatory themes that also apply to other secretory 
cells. Additional mechanistic studies will further reveal the 
specific modalities of actin regulation for exocytic processes 
under normal and pathophysiological conditions.
stimulation with PMA/ionomycin or antigen-specific trig-
gering of FcRI induced the transient relocation of a sub-
stantial amount of Coro1a and Coro1b from the particulate 
fraction into the cytosolic fraction (Fig. 4 c). The kinetics of 
the subcellular redistribution of Coro1a and Coro1b upon 
MC  activation  resembled  the  phosphorylation  kinetics  of 
Coro1a and Coro1b. Moreover, the subcellular relocation of 
Coro1b correlated with the detection of Coro1b phosphory-
lation on Ser2 in the cytosolic fraction (Fig. 4 c). Together, 
these data suggest that the intracellular distribution of Coro1a 
and Coro1b in MCs might be determined by their phos-
phorylation status.
To  test  this  hypothesis,  we  reconstituted  Coro1a/ 
BMMCs with Flag-tagged Coro1a mutants that affect Coro1a 
Ser2  phosphorylation  and/or  its  ability  to  bind  F-actin   
and  examined  their  subcellular  localization.  As  expected,   
WT Coro1a mainly localized to the F-actin–rich cell cortex 
(Fig. 5 a, 13) and was predominantly detected in the detergent-
insoluble cytoskeletal fraction (Fig. 5 b, lane 2). Similarly, the 
Coro1a-S2A  mutant,  which  cannot  be  phosphorylated   
at Ser2, also exhibited strong colocalization with the actin   
cytoskeleton (Fig. 5 a, 14). In striking contrast, the phos-
phomimetic  Coro1a-S2D  mutant,  which  lacks  Arp2/3- 
binding activity (Föger et al., 2006), was mainly found in 
the detergent-soluble cytosolic fraction and showed severely 
compromised cortical staining (Fig. 5 a, 15). The F-actin–
binding mutant Coro1a-R29E (Tsujita et al., 2010) and the 
Coro1a-S2D-R29E double mutant were almost exclusively 
detected in the cytoplasmic fraction and exhibited mainly 
cytoplasmic staining (Fig. 5 a, 16 and 17). Although poorly 
expressed, Coro1a-CC, which lacks the C-terminal coiled-
coil domain, was also primarily found in the cytosolic frac-
tion. Collectively, our data suggest that the cortical localization 
of Coro1a in BMMCs is largely determined by Ser2 phos-
phorylation and the F-actin–binding activity of Coro1a.
Next, we investigated the ability of Coro1a mutants   
to  negatively  regulate  FcRI-induced  degranulation  in 
BMMCs. Reconstitution of Coro1a/Coro1b/ BMMCs 
with WT Coro1a or Coro1a-S2A resulted in a profound re-
duction in degranulation, as assessed by CD107a surface stain-
ing on transfected (GFP+) cells (Fig. 5 c). In marked contrast, 
hyperdegranulation  of  Coro1a/Coro1b/  BMMCs  was 
minimally restored by expression of mutant Coro1a-S2D and, 
even  less  so,  by  Coro1a-R29E  and  Coro1a-S2D-R29E 
(Fig. 5 c). Together, these results demonstrate that Coro1a 
negatively regulates MC degranulation via an actin-depen-
dent mechanism.
Our study reveals a dual function of coronin proteins and 
the actin cytoskeleton on secretory processes in MCs: regu-
lation of MC degranulation and facilitation of cytokine re-
lease. Hyperdegranulation of Coro1a/Coro1b/ deficient 
BMMCs correlates with enhanced cutaneous anaphylaxis in 
vivo, suggesting a role of coronin proteins in the pathophysiol-
ogy of allergic disorders. The negative regulatory function of 
Coro1a on MC degranulation strictly correlates with cortical 
localization of Coro1a and requires the F-actin–binding site JEM Vol. 208, No. 9  1785
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sensitized cells were activated with DNP-HSA in Tyrode’s buffer (10 mM 
Hepes, pH 7.4, 130 mM NaCl, 5 mM KCl, 1.4 mM CaCl2, 1 mM MgCl2, 
5.6 mM glucose, and 0.1% [wt/vol] BSA). Supernatant or cell pellets solubi-
lized with 1% Triton X-100 in Tyrode’s buffer were incubated with p-nitro-
phenyl-N-acetyl-D-glucosamide  (Sigma-Aldrich;  1.3  mg/ml  in  0.1  M 
citrate, pH 4.5), and color was developed for 30 min at 37°C. The enzyme 
reaction was stopped by the addition of 0.2 M Gly-NaOH, pH 10.7, and the 
absorbance at 405 nm was measured. The percentage of -hexosaminidase 
released was calculated by dividing the absorbance in the supernatant by the 
sum  of  the  absorbance  in  the  supernatant  and  detergent-solubilized  cell   
pellet. Statistical analysis was performed by two-tailed Student’s t test. De-
granulation was also assessed by flow cytometric measurement of the surface 
expression of CD107a (Lamp1).
Measurement  of  cytokines. Sensitized BMMCs were stimulated with 
DNP-HSA for 4 h at 37°C, and cytokines in cell supernatants were analyzed 
by ELISA. Coating and detection antibodies for TNF and IL-6 and protein 
standards were purchased from R&D Systems. For the detection of intracel-
lular cytokines, cells were stimulated for 4 h in the presence of Brefeldin   
A (eBioscience) for blockade of Golgi function. Cells were fixed with 4% 
PFA in PBS, permeabilized, and subjected to intracellular FACS staining   
using antibodies against IL-6 and TNF.
Immunofluorescence microscopy. Cells were fixed with 4% PFA and 
permeabilized with 0.2% Triton X-100 in PBS. After blocking, immuno-
fluorescence labeling was performed according to standard procedures using 
directly labeled antibodies against Coro1a and CD107a (Lamp1). Coro1b 
was detected by using anti–hamster IgG-DyLight649 secondary antibody. 
Specificity of the coronin staining was confirmed by using Coro1a/ or 
Coro1b/ BMMCs as controls. F-actin and DNA were visualized by stain-
ing with phalloidin (Invitrogen) and DAPI (Invitrogen), respectively. Con-
focal images were acquired on a microscope (TCS Sp5; Leica). Subsequent 
image  analysis  was  performed  using  iVision  software  (BioVision Tech-
nologies). For each staining, at least 50–100 cells were analyzed. Selected pic-
tures show patterns that were representative for at least 75% of cells (for 
stimulated conditions, only cells that showed signs of cellular activation   
were considered). The Pearson’s correlation coefficient as a measure for the 
extent of colocalization was calculated using iVisionEvaluation software 
(BioVision Technologies).
RT-PCR and real-time quantitative RT-PCR analysis. Total RNA was 
purified from BMMCs using the RNeasy system (QIAGEN) according to 
the manufacturer’s instructions and reverse transcribed using the Superscript II 
first-strand synthesis system (Invitrogen). For some experiments, the Fast-
Lane cDNA kit (QIAGEN) was used. Primers and conditions for standard 
PCR to detect MC proteases were described previously (Orinska et al., 
2010). Mouse MCP-1 was detected with sense (5-AAAGCCCCCTGCA-
GTCTTCACC-3) and antisense (5-AGCTGCTGGAGGTTAGGTC-3) 
primers. PCR products were separated on an agarose gel, stained with ethid-
ium bromide, and photographed. For real-time quantitative RT-PCR, IL-6, 
TNF, and IL-13 gene expression was measured relative to HPRT using the 
Universal ProbeLibrary (Roche) TaqMan-based system. Amplification was 
performed in a fluorescence temperature cycler (Light Cycler 2.0; Roche). 
Primers and the Universal ProbeLibrary ID numbers are listed in Table S1.
Western blotting and immunoprecipitation. After stimulation of sen-
sitized BMMCs with DNP-HSA or PMA/ionomycin, cells were lysed in 
cell extraction buffer: 1% NP-40, 50 mM Tris-HCl buffer, pH 8.0, 150 mM 
NaCl, 10 mM Na fluoride, 1 mM Na orthovanadate, and protease inhibi-
tors (complete protease inhibitor cocktail; Roche). For immunoprecipita-
tion experiments, cell lysates were precleared with protein A beads and 
subsequently incubated for 1–2 h with protein A beads covalently coupled 
with anti-Coro1a mAb. Immune complexes were washed four times with 
cell extraction buffer. Eluted samples or whole cellular lysates were resolved   
by SDS-PAGE, and proteins were detected by Western blotting using the   
MATERIALS AND METHODS
Mice. Coro1a-deficient mice were reported previously (Föger et al., 2006). 
Coro1b-deficient mice were generated using homologous recombination in 
embryonic stem cells as described in Fig. S2 a. Heterozygous mice were 
backcrossed for >10 generations onto C57BL/6N mice. Coro1a/Coro1b 
double-deficient mice were obtained by interbreeding Coro1a- and Coro1b-
deficient mice. Mice were housed under specific pathogen–free conditions at 
the Animal Care Facility of the Research Center Borstel. Animal experi-
ments were performed in accordance with institutional guidelines and were 
approved by the local authorities (Ministry of Agriculture, the Environment, 
and Rural Areas, Schleswig-Holstein).
Antibodies  and  reagents.  Fluorescent  labeled  antibodies  specific  for   
c-Kit, FcRI, TNF, IL-6, CD3, CD11b, CD11c, CD107a, and B220 were 
all obtained from eBioscience, and anti-T1/ST2 was obtained from MD Bio-
sciences. Anti-DNP IgE (SPE-7) was purchased from Sigma-Aldrich. Anti-
bodies to p-SerPKC (phospho-[Ser] PKC substrate), p-JNK1/2 (Thr183/Tyr185), 
p-p90Rsk  (Ser380),  p-Akt  (Ser473),  p-Erk1/2  (Thr202/Tyr204),  p-p38 
(Thr180/Tyr182), and p38 were obtained from Cell Signaling Technology. 
Antibodies to GAPDH (6C5), Erk-2 (C-14), and -actin were purchased   
from Santa Cruz Biotechnology, Inc. Vimentin-specific antibody and FcBlock 
(anti-CD16/CD32) were obtained from BD. Anti–p-Ser2-Coro1b was pur-
chased from ECM Biosciences. Antibodies to Coro1a and Coro1b have been   
described previously (Föger et al., 2006). Fluorescent-labeled secondary anti-
bodies  were  obtained  from  Jackson  ImmunoResearch  Laboratories,  Inc. 
PMA and ionomycin were both purchased from Sigma-Aldrich. Latrunculin B 
was obtained from Enzo Life Sciences.
PCA. For the induction of PCA, mice were sensitized by intradermal in-
jection in both ears of 10 µl anti-DNP IgE (SPE-7) diluted in PBS (50 ng 
IgE per ear, twice) or PBS as a control. Mice were challenged by i.v. injec-
tion of 200 µg DNP-HSA (Sigma-Aldrich) in 100 µl PBS 48 h later.   
Ear thickness was measured before antigen injection and 1, 2, 4, and 6 h   
after antigen injection using a dial thickness gauge (Mitutoyo). The re-
searcher  conducting  the  in  vivo  experiments  was  blinded  to  the  ex-
perimental design.
Cell isolation, generation, culture, and activation. Peritoneal cells were 
isolated by peritoneal lavage with 10 ml of cold 0.9% NaCl solution. BMMCs 
were prepared as described previously (Orinska et al., 2007). In brief, BM 
cells were flushed from femurs, and the MCs were selectively grown in MC 
medium (IMDM supplemented with 10% FBS, 50 µM -mercaptoethanol, 
2 mM l-glutamine, penicillin, streptomycin, nonessential amino acids, vita-
mins,  and  Na-pyruvate)  in  the  presence  of  10  ng/ml  recombinant  IL-3 
(R&D Systems) for 5–10 wk. Cell purity was routinely checked by flow cyto-
metric analysis of c-Kit, FcRI-, and T1/ST2 cell surface expression. After 
sensitization of the cells overnight with 200 ng/ml anti-DNP IgE (SPE-7)   
in MC medium containing 1 ng/ml IL-3, cells were activated with the indi-
cated concentrations of DNP-HSA. Where indicated, cells were preincu-
bated  with  1  µg/ml  latrunculin  B  for  15  min  at  37°C.  BM-derived 
macrophages and BM-derived DCs were differentiated by culturing BM 
cells for 8–9 d in the presence of either 20 ng/ml M-CSF (BM-derived 
macrophages) or 20 ng/ml GM-CSF (BM-derived DCs).
Flow  cytometric  analysis.  Single  cell  suspensions  of  BMMCs  were 
blocked with FcBlock (anti-CD16/CD32; BD) and subsequently stained 
with fluorescent-labeled mAbs. To assess the cellular F-actin content, cells 
were fixed in 4% paraformaldehyde (PFA) in PBS, permeabilized with 0.2% 
Triton X-100, and stained with fluorescence-conjugated phalloidin (Invitro-
gen). Intracellular staining of cytokines was performed in permeabilized cells 
according to standard procedures. Flow cytometric measurements were per-
formed on a FACSCalibur and an LSRII (both BD). Data were analyzed 
with FlowJo software (version 8.8.6; Tree Star).
Measurement of degranulation. MC degranulation was assessed by mea-
suring the release of -hexosaminidase activity (Orinska et al., 2010). In brief, 1786 Coronins regulate secretory pathways in mast cells | Föger et al.
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indicated antibodies. Densitometric analysis was performed using ImageJ 
software (National Institutes of Health; Tables S3–S9).
Isolation of the cytoskeleton-rich fraction. Subcellular fractionation 
and isolation of the cytoskeleton-containing detergent-insoluble fraction was 
performed according to Gatfield et al. (2005). In brief, cell pellets (106 cells) 
were suspended in 0.3 ml of ice-cold cytoskeletal isolation buffer (1% Triton 
X-100 in 80 mM Pipes, pH 6.8, 5 mM EGTA, and 1 mM MgCl2) and im-
mediately centrifuged at 3,000 g for 3 min to obtain the detergent-insoluble 
cytoskeleton-containing fraction and the detergent-soluble cytosolic fraction. 
Equal cell equivalents were subjected to SDS-PAGE and Western blotting.
Expression constructs and transient transfection of BMMCs. Coro-
nin expression constructs were cloned into the bicistronic expression vector 
pIRES2-EGFP  (Takara  Bio  Inc.).  Full-length  mouse  Coro1a  (aa  1–461)   
carrying a C-terminal Flag tag, as well as Coro1a-S2A and Coro1a-S2D mutants 
and the coiled-coil deletion (CC) mutant of Coro1a have been described 
previously  (Föger  et  al.,  2006). The  actin-binding  mutant  Coro1a-R29E 
(Tsujita et al., 2010) and the Coro1a-S2D-R29E double mutant were gener-
ated using the QuikChange site-directed mutagenesis kit (Agilent Technolo-
gies).  Constructs  were  transfected  into  BMMCs  using  the  Nucleofector 
system (solution T and program T-16) according to the method described by 
Jeffrey et al. (2006). After transfection, cells were allowed to recover for 24 h 
in MC medium containing 1 ng/ml IL-3. Cells were then sensitized with 
anti–DNP-HSA and stimulated with DNP-HSA. MC degranulation was as-
sessed by flow cytometric analysis of CD107a cell surface expression. Trans-
fected cells were identified on the basis of their GFP expression. Dead cells 
were excluded by propidium iodide staining. FcRI-induced degranulation 
in control-transfected cells (empty vector control) was >20% in all of the ex-
periments. Equal expression levels of coronin constructs in transfected BMMCs 
were controlled by intracellular FACS staining for Coro1a (Fig. S5 a).
Online supplemental material. Fig. S1 shows mRNA expression levels of 
coronin family members in different tissues and cell types, demonstrates the 
specificity of the Coro1a and Coro1b staining in confocal microscopy ex-
periments, and also shows reduced activation-induced Ser phosphorylation 
of the Coro1a-S2A mutant compared with WT Coro1a. Fig. S2 describes the 
generation of Coro1b-deficient mice, shows the expression of Coro1a and 
Cora1b in peritoneal MCs, and demonstrates normal in vivo development of 
Coro1a/Coro1b/ MCs. Fig. S3 shows the total cellular -hexosaminidase 
content, as well as FcRI-induced degranulation, calcium mobilization, and 
intracellular cytokine production in WT and coronin-deficient BMMCs.   
Fig. S4 depicts relative cellular F-actin contents in naive CD4+ T cells and 
BMMCs, as well as relative changes in F-actin levels upon FcRI stimulation 
and the subcellular redistribution of Coro1a upon MC activation. Fig. S5 
shows functional reconstitution of MC degranulation upon expression of 
different coronin constructs in Coro1a/Coro1b/ BMMCs. Table S1 describes 
primers and Universal ProbeLibrary ID numbers used for quantitative real-time 
PCR analysis. Table S2 provides an analysis of confocal pictures by determining 
the Pearson’s correlation coefficient as a measure of colocalization. Tables S3–S9 
show the densitometric analysis of immunoblots. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20101757/DC1.
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